Explain this page
Arphra AIPlain-English read on UnitedHealth Group Incorporated’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$960.63
+135.15% vs spot
Recommendation
Strong Buy
18 of 19 methods
Method spread
9bull9bear
±5% threshold
Analyst PT consensus: $417.25 (+2.14%)
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.73% | +2.87% | +1.83% | +44.82% | +19.51% | +23.75% | +30.30% | -16.85% | +2.34% | +195.84% | +282554.12% |
Insider · 30d
History →Bought
$32.12M
6 txns
Sold
$912.25K
4 txns
Net flow
+$31.21M
Aftermarket
LiveLast trade
$408.68
Bid
$408.10
40 sh
Ask
$408.99
1 sh
Spread
$0.890
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 Mar 2026 | $111.72B | $6.28B | $6.90 |
| Q4 Dec 2025 | $113.22B | $10M | $0.01 |
| Q3 Sep 2025 | $113.16B | $2.35B | $2.59 |
| Q2 Jun 2025 | $111.62B | $3.41B | $3.74 |
| Q1 Mar 2025 | $109.58B | $6.29B | $6.85 |
| Q4 Dec 2024 | $100.81B | $5.54B | $5.98 |
Analyst view
DB · price_targets + analyst_gradesConsensus target
$417.25
+2.14% upside
Low
$345.00
Median
$417.00
High
$492.00
Recent actions
0 ↑0 ↓8 hold
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
- Dec 01, 2025
News
DB · news_items- UnitedHealth Group Just Hit a 52-Week High. Is It Too Late to Buy This Soaring Stock?fool.com·Jun 11, 2026
- UnitedHealth Group Announces Earnings Release Datebusinesswire.com·Jun 11, 2026
- UnitedHealth Group Announces Earnings Release Datebusinesswire.com·Jun 11, 2026
- UnitedHealth Group (UNH) is a Top-Ranked Momentum Stock: Should You Buy?zacks.com·Jun 10, 2026
- UnitedHealth Group (UNH) is a Top-Ranked Value Stock: Should You Buy?zacks.com·Jun 08, 2026
- UnitedHealth, Eli Lilly Lead Healthcare Rebound as Investors Seek Stabilitygurufocus.com·Jun 05, 2026
- UnitedHealth Stock Jumps 20% YTD: Should Investors Jump in Too?zacks.com·Jun 05, 2026
- UnitedHealth Positioned As AI Leader: Analystfeeds.benzinga.com·Jun 05, 2026
Recent analyst activity
DB- Jun 11, 2026GradeOverweight → OverweightUnitedHealth Group (UNH) Reiterate at Overweight by Cantor FitzgeraldCantor Fitzgerald
- Jun 08, 2026PT$460.00UnitedHealth price target raised to $460 from $440 at MizuhoMizuho Securities
- Jun 04, 2026GradeBuy → NeutralMidday Fly By: Broadcom posts Q2 beat, Five Below reports 'beat and raise'UBS
- Jun 04, 2026GradeOutperform → NeutralBroadcom downgraded, UnitedHealth upgraded: Wall Street's top analyst callsMacquarie
- Jun 04, 2026PT$453.00UnitedHealth price target raised to $453 from $395 at Morgan StanleyMorgan Stanley
- Jun 04, 2026GradeOverweight → OverweightUnitedHealth price target raised to $453 from $395 at Morgan StanleyMorgan Stanley
- Jun 04, 2026GradeBuyBofA Securities Upgrades UnitedHealth Group (UNH) to BuyBank of America Securities
- Jun 01, 2026PT$440.00UnitedHealth price target raised to $440 from $395 at TruistTruist Financial
Peers
Total assets
$309.58B
Total debt
$78.39B
Cash & equiv
$24.37B
Operating CF
$19.7B
Free cash flow
$16.08B
Buybacks
-$5.55B
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
Conway Patrick Hugh officer: Chief Executive Officer, Optum | Sell | 800 | $284K | Apr 23, 2026 |
Baker Charles D. director | Sell | 27 | $9.61K | Sep 11, 2025 |
Conway Patrick Hugh officer: Chief Executive Officer, Optum | Sell | 589 | $179.65K | Jun 10, 2025 |
REX JOHN F officer: President & CFO | Buy | 17,175 | $5M | May 16, 2025 |
HEMSLEY STEPHEN J director, officer: CEO, UHG | Buy | 86,700 | $25.02M | May 16, 2025 |
Gil Kristen director | Buy | 3,700 | $1M | May 15, 2025 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $447.57B | $18.96B | $12.06B | $13.23 | +2.69% |
| FY 2024 | $400.28B | $32.29B | $14.41B | $15.51 | +3.60% |
| FY 2023 | $371.62B | $32.36B | $22.38B | $23.86 | +6.02% |
| FY 2022 | $324.16B | $28.44B | $20.12B | $21.18 | +6.21% |
| FY 2021 | $287.6B | $23.97B | $17.29B | $18.08 | +6.01% |